RXD ETF — ProShares UltraShort Health Care

ProShares UltraShort Health Care (RXD)

Updated October 16, 2026.

RXD is an ETF. its distribution rate is 3.66%, its trailing-12-month yield is 3.33%, its expense ratio is 0.95%. Total return is -99.4% over the past 19.7 years, 756.0 points behind SPY at 656.6%.

ProShares UltraShort Health Care is an ETF that seeks inverse leveraged exposure to health care companies in the S&P 500 Index, making it designed to profit when health care stocks decline. The fund carries a modest current distribution rate with quarterly distributions and a 0.95% expense ratio. This fund appeals primarily to tactical traders and hedging-focused investors seeking to offset or bet against health care sector exposure, rather than income-focused investors.

RXD performance versus SPY

Price and return data through 2026-10-16.

Total return is -99.4% over the past 19.7 years, 756.0 points behind SPY at 656.6%. Over the past year its total return — price change plus distributions reinvested — is -35.7%. Its deepest 1-year drawdown was 36.6%.

RXD key facts

Issuer

ProShares

Asset type

ETF

Asset class

Equity

Inception date

01/30/2007

Expense ratio

0.95%

Distribution rate

3.66%

Distribution frequency

Quarterly

Trailing yield

3.33%

Last close

$13.56 (as of 2026-10-16)

AUM

$3,486,320

Average volume

3801.0

Dividend

$0.124

Ex-dividend date

09/23/2026

Payment date

09/29/2026

Beta

-0.9

How Dividend Vision calculates yield and returns

Distribution rate (3.66%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (3.33%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: ProShares; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

RXD risks and drawbacks

RXD's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 36.6%.

Who may consider RXD — and who may not

RXD may suit someone looking for moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (RXD pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on RXD

• All tickers starting with R

Tagged: Leverage, Short.

Frequently asked questions

More securities from ProShares.